vimarsana.com
Home
Live Updates
Starna Therapeutics - Breaking News
Pages:
Starna Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
The biggest Asia-Pacific biotech investments in May 2022
Healthcare-focused biotech companies won the biggest private investments in the Asia-Pacific region in May 2022, led by a $100 million Series A from the Chinese anti-inflammatory drug developer Reistone Biopharma.
New zealand
Hong kong
Yuanneng bio
Elena resko
Reistone biopharma
Laekna therapeutics
Full life technologies
Starna therapeutics
Ankere therapeutics
Insilico medicine
China Digest: Genfine Biotech nets $15m; Starna Therapeutics snags $10m
Genfine Biotech (Beijing) and Starna Therapeutics have raised funding.
Genfine biotech beijing co ltd
China merchants group securities
Changping technology industrial park
Genfine biotech
Starna therapeutics
China merchants group
China merchants securities
China merchants securities capital
Beijing changping technology industrial park
Legend capital
Sequoia capital china
Sherpa healthcare partners
vimarsana © 2020. All Rights Reserved.